Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
about
Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiencyUrsodeoxycholic acid treatment in children with Byler diseaseLiver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.Increasing ursodeoxycholic acid in the enterohepatic circulation of pigs through the administration of living bacteria.Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.Cystic fibrosis patients with liver disease are not genetically distinct.Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.One-step synthesis of 12-ketoursodeoxycholic acid from dehydrocholic acid using a multienzymatic system.Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study.Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review.Identification, cloning, heterologous expression, and characterization of a NADPH-dependent 7β-hydroxysteroid dehydrogenase from Collinsella aerofaciens.
P2860
Q24806288-C1147AFF-0984-4BFF-9A92-64123F5E52D1Q28378329-4C702CF3-FE01-461A-8DEA-B3C68A0B40DFQ33623427-853907EC-F46A-4C99-A561-95B42A0B5AE9Q34992341-A2482FB3-BD1F-4231-867A-60E123A52488Q40415330-910D97E9-FB22-48C1-A37F-5596B465B2B1Q40573407-9164E97F-866C-4A4A-BAF4-8D09BB619F2CQ43146231-2C1E17E3-E76D-4E1E-ACAB-F7D6A0E01267Q43226120-777DB012-4510-48DE-BCE3-D70D558CC881Q44111064-9CCB9416-E15D-4BE0-B96C-E629AEE5848FQ44605301-58BFDC55-4EED-46C4-A205-5C9501BA270DQ47198958-88E71033-41BF-4B13-BD2E-6D88CCA5306CQ48190174-DFD1FB80-67A3-4F5D-8493-24BBB0DFA8D5Q51742557-C92FF1B2-28B2-4099-95A3-98388AC01CCCQ54373587-6A460637-C231-40DC-A2AD-CA0F7828A1C6
P2860
Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Effects of ursodeoxycholic aci ...... sociated with cystic fibrosis.
@en
Effects of ursodeoxycholic aci ...... sociated with cystic fibrosis.
@nl
type
label
Effects of ursodeoxycholic aci ...... sociated with cystic fibrosis.
@en
Effects of ursodeoxycholic aci ...... sociated with cystic fibrosis.
@nl
prefLabel
Effects of ursodeoxycholic aci ...... sociated with cystic fibrosis.
@en
Effects of ursodeoxycholic aci ...... sociated with cystic fibrosis.
@nl
P2093
P1476
Effects of ursodeoxycholic aci ...... sociated with cystic fibrosis.
@en
P2093
Crosignani A
Setchell KD
P304
P356
10.1016/S0022-3476(05)81103-5
P407
P577
1990-09-01T00:00:00Z